A query of the 6 selected genes (CDKN2A, EGFR, HRAS, KRAS, PTEN and TP53) identified in the glioma pathway was performed, and these genes were analyzed in the 5 glioma studies. This evidence concerns the gene KRAS and central nervous system cancer.